Report : Asia Pacific Arterial Blood Gas Kits Market Forecast to 2030 – Regional Analysis – by Product (Luer Lock Syringe and Luer Slip Syringe), Type (Non-Vented and Vented), Usage (Pre-set plunger mode and Manual Aspiration), Application (In vitro diagnostics, Electrolyte Analysis, and pH blood gas), Needle Gauge (23 G to 25 G and Less than 23 G), Syringe Volume (1 ml, 3 ml, and Others), and End User (Hospitals, Clinics, and Others)
At 7.6% CAGR, the Asia Pacific Arterial Blood Gas Kits Market is Speculated to be Worth US$ 270.34 million by 2030, says The Business Market Insights
According to the Business Market Insights’ research, the Asia Pacific Arterial blood gas kits market was valued at US$ 150.54 million in 2022 and is expected to reach US$ 270.34 million by 2030, registering a CAGR of 7.6% from 2022 to 2030. Increasing prevalence of respiratory diseases and growing prevalence of metabolic and kidney diseases are the critical factors attributed to the Asia Pacific arterial blood gas kits market expansion.
Kidney, respiratory, and metabolic diseases are prevalent in the geriatric population. According to the Technical Group on Population Projections for India and States 2011–2036, there will be ∼ 138 million senior people in India by 2031 (67 million men and 71 million women), up from the current estimate of 117 million. Surging geriatric population worldwide is expected to increase the prevalence of chronic disorders in the future, which is likely to create lucrative opportunities for the arterial blood gas kits market.
On the contrary, risks, complications, and sampling errors associated with arterial blood sampling hurdles the growth of Asia Pacific arterial blood gas kits market.
Based on product, the Asia Pacific arterial blood gas kits market is segmented into luer lock syringe and luer slip syringe. The luer lock syringe segment held 74.3% share of Asia Pacific arterial blood gas kits market in 2022, amassing US$ 111.90 million. It is projected to garner US$ 211.77 million by 2030 to expand at 8.3% CAGR during 2022–2030.
Based on type, the Asia Pacific arterial blood gas kits market is segmented into vented and non-vented. The non-vented segment held 78.4% share of Asia Pacific arterial blood gas kits market in 2022, amassing US$ 117.96 million. It is projected to garner US$ 217.24 million by 2030 to expand at 7.9% CAGR during 2022–2030.
Based on usage, the Asia Pacific arterial blood gas kits market is segmented into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held 81.3% share of Asia Pacific arterial blood gas kits market in 2022, amassing US$ 122.42 million. It is projected to garner US$ 228.55 million by 2030 to expand at 8.1% CAGR during 2022–2030.
Based on application, the Asia Pacific arterial blood gas kits market is segmented into In vitro diagnostics, electrolyte analysis, and pH blood gas. The In vitro diagnostics segment held 42.5% share of Asia Pacific arterial blood gas kits market in 2022, amassing US$ 63.92 million. It is projected to garner US$ 120.16 million by 2030 to expand at 8.2% CAGR during 2022–2030.
Based on needle guage, the Asia Pacific arterial blood gas kits market is segmented into 23 G to 25 G and less than 23 G. The 23 G to 25 G segment held 72.2% share of Asia Pacific arterial blood gas kits market in 2022, amassing US$ 108.72 million. It is projected to garner US$ 200.65 million by 2030 to expand at 8.0% CAGR during 2022–2030.
Based on syringe volume, the Asia Pacific arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3 ml segment held 46.4% share of Asia Pacific arterial blood gas kits market in 2022, amassing US$ 69.80 million. It is projected to garner US$ 128.54 million by 2030 to expand at 7.9% CAGR during 2022–2030.
Based on end user, the Asia Pacific arterial blood gas kits market is segmented into hospitals, clinics, and others. The hospitals segment held 51.9% share of Asia Pacific arterial blood gas kits market in 2022, amassing US$ 78.12 million. It is projected to garner US$ 141.79 million by 2030 to expand at 7.7% CAGR during 2022–2030.
Based on country, the Asia Pacific arterial blood gas kits market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.4% share of Asia Pacific arterial blood gas kits market in 2022. It was assessed at US$ 41.22 million in 2022 and is likely to hit US$ 76.43 million by 2030, exhibiting a CAGR of 8.0% during 2022–2030.
Key players operating in the Asia Pacific arterial blood gas kits market Becton Dickinson and Co, Cardinal Health Inc, Fisher Scientific International Inc, ICU Medical Inc, ITL health Group Ltd, Medline Industries LP, Medline Industries LP, Radiometer Medical ApS, Siemens Healthineers AG, Teleflex Inc, and Vyaire Medical Inc, among others.
- In April 2022, Siemens Healthineers has received U.S. Food and Drug Administration approval for RAPIDPoint 500e Blood Gas Analyzer. RAPIDLyte Arterial Sampling Syringes and RAPIDLyte Multicap Capillaries offered by Siemens are compatible with RAPIDPoint 500e Blood Gas System. This product approval strengthens the market position of the company.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com